Literature DB >> 24911952

Possible involvement of VEGF signaling system in rescuing effect of endogenous acetylcholine on NMDA-induced long-lasting hippocampal cell damage in organotypic hippocampal slice cultures.

Chikako Inada1, Yimin Niu2, Kinzo Matsumoto3, Xoan Thi Le4, Hironori Fujiwara5.   

Abstract

In our previous study, elevation of endogenous acetylcholine (ACh) by tacrine (THA) rescued NMDA-induced long-lasting hippocampal cell damage via muscarinic M1 receptors. However, the detailed molecular mechanism underlying the effect of ACh is unclear. This study investigated possible involvement of the VEGF signaling system in the rescuing effect of ACh on N-methyl-d-aspartate (NMDA)-induced long-lasting hippocampal cell damage using organotypic hippocampal slice cultures (OHSCs). As previously reported, NMDA pretreatment caused long-lasting hippocampal cell damage in OHSCs in a manner reversible by treatment with THA. The protein kinase C (PKC) inhibitor Ro31-8220, but not the extracellular signal-regulated kinase (ERK) inhibitor U0126, dose-dependently and almost completely abolished the effect of THA. The rescuing effect of THA was also partially but significantly blocked by Ki8751, a selective inhibitor of type 2 vascular endothelial growth factor (VEGF) receptor (VEGFR-2) tyrosine kinase. NMDA pretreatment elevated the expression level of HIF1α, whereas it decreased the expression of VEGF-A. Moreover, NMDA pretreatment reduced the level of phosphorylated VEGFR-2 without apparently affecting the level of VEGFR-2 or β-actin. These NMDA pretreatment-induced changes were significantly attenuated by THA treatment. Immunohistochemical analysis conducted 6days after NMDA pretreatment revealed that VEGF-A and VEGFR-2 were mainly expressed on astrocytes and neurons, respectively, in OHSCs. In OHSCs pretreated with NMDA, THA treatment induced a morphological and activation-related change in astrocytes expressing VEGF-A. The present results demonstrate that endogenous acetylcholine plays a rescuing role towards excitotoxicity-induced long-lasting hippocampal cell damage in part via paracrine VEGF signaling between astrocytes and hippocampal neurons or autocrine VEGF signaling in hippocampal neurons in OHSCs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endogenous acetylcholine; Excitotoxicity; Organotypic hippocampal slice cultures; PKC; Rescuing/protecting activity; VEGF-A-VEGFR-2 signaling

Mesh:

Substances:

Year:  2014        PMID: 24911952     DOI: 10.1016/j.neuint.2014.05.009

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  4 in total

1.  Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers.

Authors:  Ni Fan; Minling Zhang; Ke Xu; Xiaoyin Ke; Yi Ding; Daping Wang; Yuping Liu; Yuping Ning; Xuefeng Deng; Hongbo He
Journal:  Drug Alcohol Depend       Date:  2015-05-08       Impact factor: 4.492

2.  Ursolic acid and its isomer oleanolic acid are responsible for the anti-dementia effects of Ocimum sanctum in olfactory bulbectomized mice.

Authors:  Hien Thu Nguyen; Xoan Thi Le; Tai Van Nguyen; Hoa Nhu Phung; Hang Thi Nguyet Pham; Khoi Minh Nguyen; Kinzo Matsumoto
Journal:  J Nat Med       Date:  2022-02-26       Impact factor: 2.343

3.  Ocimum sanctum Linn. Extract Improves Cognitive Deficits in Olfactory Bulbectomized Mice via the Enhancement of Central Cholinergic Systems and VEGF Expression.

Authors:  Xoan Thi Le; Hien Thu Nguyen; Tai Van Nguyen; Hang Thi Nguyet Pham; Phuong Thi Nguyen; Khoi Minh Nguyen; Ba Van Nguyen; Kinzo Matsumoto
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

4.  Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth Factor.

Authors:  Carla Letizia Busceti; Luisa Di Menna; Franca Bianchi; Federica Mastroiacovo; Paola Di Pietro; Anna Traficante; Giovanna Bozza; Christof Niehrs; Giuseppe Battaglia; Valeria Bruno; Francesco Fornai; Massimo Volpe; Speranza Rubattu; Ferdinando Nicoletti
Journal:  Front Cell Neurosci       Date:  2018-09-11       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.